Bausch Health Cos., Inc. (BHC)
5.67
+0.02
(+0.35%)
USD |
NYSE |
Sep 18, 16:00
6.34
+0.67
(+11.82%)
Pre-Market: 07:39
Bausch Health Cos. Price : 5.67 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 5.68 | 5.725 | 5.60 | 5.67 | 1.913M |
| Sep 17, 2026 | 5.78 | 5.78 | 5.625 | 5.65 | 2.865M |
| Sep 16, 2026 | 5.69 | 5.825 | 5.645 | 5.69 | 1.566M |
| Sep 15, 2026 | 5.90 | 5.91 | 5.635 | 5.67 | 1.612M |
| Sep 14, 2026 | 5.93 | 6.06 | 5.83 | 5.92 | 5.204M |
| Sep 11, 2026 | 6.124 | 6.125 | 5.835 | 5.86 | 2.407M |
| Sep 10, 2026 | 6.11 | 6.165 | 5.88 | 6.07 | 1.592M |
| Sep 09, 2026 | 6.38 | 6.47 | 6.14 | 6.16 | 1.426M |
| Sep 08, 2026 | 6.57 | 6.685 | 6.41 | 6.43 | 1.838M |
| Sep 04, 2026 | 6.71 | 6.72 | 6.52 | 6.56 | 1.653M |
| Sep 03, 2026 | 6.905 | 6.99 | 6.62 | 6.76 | 2.158M |
| Sep 02, 2026 | 6.56 | 6.87 | 6.535 | 6.83 | 7.721M |
| Sep 01, 2026 | 6.39 | 6.74 | 6.34 | 6.47 | 2.563M |
| Aug 31, 2026 | 6.36 | 6.375 | 6.135 | 6.37 | 2.509M |
| Aug 28, 2026 | 6.29 | 6.359 | 6.23 | 6.32 | 1.392M |
| Aug 27, 2026 | 6.47 | 6.47 | 6.29 | 6.30 | 2.894M |
| Aug 26, 2026 | 6.69 | 6.82 | 6.50 | 6.51 | 2.142M |
| Aug 25, 2026 | 6.736 | 6.74 | 6.455 | 6.73 | 3.456M |
| Aug 24, 2026 | 6.44 | 6.71 | 6.43 | 6.68 | 2.713M |
| Aug 21, 2026 | 6.80 | 6.87 | 6.375 | 6.44 | 4.021M |
| Aug 20, 2026 | 6.82 | 6.91 | 6.67 | 6.81 | 1.933M |
| Aug 19, 2026 | 6.99 | 7.08 | 6.715 | 6.89 | 2.503M |
| Aug 18, 2026 | 6.64 | 7.03 | 6.58 | 6.93 | 4.775M |
| Aug 17, 2026 | 6.40 | 6.58 | 6.31 | 6.58 | 2.101M |
| Aug 14, 2026 | 6.30 | 6.525 | 6.18 | 6.51 | 2.561M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InMed Pharmaceuticals, Inc. | 1.36 |
| NervGen Pharma Corp. | 2.05 |
| Milestone Pharmaceuticals, Inc. | 0.9158 |
| Clearmind Medicine, Inc. | 0.7994 |
| Lexaria Bioscience Corp. | 3.24 |
Price Related Metrics
| PS Ratio | 0.1955 |
| Price to Free Cash Flow | 1.540 |
| Earnings Yield | -52.21% |
| Market Cap | 2.120B |
| Operating PE Ratio | 0.7767 |
| Normalized PE Ratio | 10.42 |